Literature DB >> 6322575

Human serum parvovirus as the cause of aplastic crisis in sickle cell disease.

J F Kelleher, N L Luban, B J Cohen, P P Mortimer.   

Abstract

An infectious agent has long been suspected as the cause of aplastic crisis in sickle cell disease, but no specific organism has been implicated. We studied six children with sickle cell disease in whom an aplastic crisis developed, looking for evidence of parvoviruslike virus (SPLV) infection using a new radioimmunoassay. All six patients had conclusive evidence of acute infection with SPLV. We postulated that SPLV is the predominant cause of aplastic crises in patients with hemolytic anemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322575     DOI: 10.1001/archpedi.1984.02140420067020

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  9 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

Review 2.  Vaccine Design Informed by Virus-Induced Immunity.

Authors:  Rhiannon R Penkert; Jane S Hankins; Neal S Young; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-05-05       Impact factor: 2.257

3.  Original Research: Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era.

Authors:  Jane S Hankins; Rhiannon R Penkert; Paul Lavoie; Li Tang; Yilun Sun; Julia L Hurwitz
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-02

4.  Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.

Authors:  L J Anderson; C Tsou; R A Parker; T L Chorba; H Wulff; P Tattersall; P P Mortimer
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

Review 5.  Erythema infectiosum and pregnancy-related complications.

Authors:  M Levy; S E Read
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

6.  Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease.

Authors:  Rhiannon R Penkert; Neal S Young; Sherri L Surman; Robert E Sealy; Jason Rosch; Philip R Dormitzer; Ethan C Settembre; Sumana Chandramouli; Susan Wong; Jane S Hankins; Julia L Hurwitz
Journal:  Vaccine       Date:  2017-05-26       Impact factor: 3.641

Review 7.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

8.  Parvovirus B19 infection in pediatric transplant patients.

Authors:  B Nour; M Green; M Michaels; J Reyes; A Tzakis; J C Gartner; L McLoughlin; T E Starzl
Journal:  Transplantation       Date:  1993-10       Impact factor: 4.939

9.  Hypothesis: Low Vitamin A and D Levels Worsen Clinical Outcomes When Children with Sickle Cell Disease Encounter Parvovirus B19.

Authors:  Rhiannon R Penkert; Melissa Azul; Robert E Sealy; Bart G Jones; Jola Dowdy; Randall T Hayden; Li Tang; A Catharine Ross; Jane S Hankins; Julia L Hurwitz
Journal:  Nutrients       Date:  2022-08-19       Impact factor: 6.706

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.